Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : ARVL save search
Immuron Travelan® sales continued strong growth
Published: 2024-04-10 (Crawled : 10:00) - globenewswire.com
IMRN | $2.46 4.94% 1.3K
|
Health Technology
|
| O: 7.08%
H: 4.75%
C: 1.36%
travelan sales growth
Digital Diagnostics Market to reach over USD 6.32 Bn by the year 2031 - Exclusive Report by InsightAce Analytic
Published: 2024-03-26 (Crawled : 10:00) - prnewswire.com
CAJPY | $28.73 -0.41% 39K
|
n/a
|
| O: 1.83%
H: 0.0%
C: -1.13%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.08%
H: 0.17%
C: -0.9%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.31%
H: 0.44%
C: 0.24%
LH 4 | $207.94 -0.01% 0.0% 790K
|
Health Services
|
| O: 0.0%
H: 0.31%
C: -0.11%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: 0.9%
H: 0.15%
C: -0.15%
NNOX | News | $9.105 -2.2% -2.25% 630K
|
Health Technology
|
| O: 0.51%
H: 1.19%
C: -6.63%
report year reach diagnostics market
A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
URGN | $14.24 -2.0% -2.04% 97K
|
Health Technology
|
| O: 2.73%
H: 12.6%
C: 2.9%
ALKS | $24.66 1.65% 1.62% 1.7M
|
Health Technology
|
| O: 0.29%
H: 0.71%
C: -0.22%
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | $0.2001 37.35% 1.5K
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.0015 14185.71% 1.3K
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | $61.51 0.69% 0.68% 2.8M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $2.03 -18.47% -22.66% 140K
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 0.91%
H: 4.5%
C: -2.7%
business year update financial results
Sandoz announces nominations to the Board of Directors and leadership change
Published: 2024-03-05 (Crawled : 06:00) - globenewswire.com
AOMFF | News | $16.53 95.45% 25
|
Producer Manufacturing
|
| O: -0.91%
H: 0.0%
C: 0.0%
ALSMY | News | $1.63 -1.78% 430K
|
Manufacturing
|
| O: -4.72%
H: 2.48%
C: 1.65%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
change
Global Exoskeleton Robots Business Report 2024-2030: As Defense Departments Lean towards Advanced Technologies, Opportunities Galore for Military Exoskeleton Robots
Published: 2024-02-23 (Crawled : 23:00) - prnewswire.com
BNKL | $0.1 -39.39% 1.8K
|
Manufacturing
| Email alert
Add to watchlist
LMT | $459.14 -0.2% -0.15% 1M
|
Electronic Technology
| Email alert
Add to watchlist
EKSO | News | $1.195 3.02% 2.93% 26K
|
Health Technology
| Email alert
Add to watchlist
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
defense report business global advanced military
MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY
Published: 2024-02-23 (Crawled : 22:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: 0.16%
H: 1.38%
C: -3.15%
mrna construction
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Published: 2024-02-22 (Crawled : 18:00) - globenewswire.com
ALSMY | News | $1.63 -1.78% 430K
|
Manufacturing
|
| O: 0.0%
H: 0.56%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.24%
C: -0.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
Immuron achieves record Travelan® sales
Published: 2024-02-13 (Crawled : 11:00) - globenewswire.com
IMRN | $2.46 4.94% 1.3K
|
Health Technology
|
| O: 3.67%
H: 1.06%
C: 1.06%
travelan sales
Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Published: 2024-02-12 (Crawled : 10:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma market
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
Published: 2024-02-04 (Crawled : 00:00) - globenewswire.com
PLRX | $11.88 -5.11% -5.39% 370K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -5.78%
liver positive fibrosis bexotegrast trial therapeutics
Immuron achieves record half yearly Travelan® sales
Published: 2024-01-16 (Crawled : 11:00) - globenewswire.com
IMRN | $2.46 4.94% 1.3K
|
Health Technology
| Email alert
Add to watchlist
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
travelan sales
NanoImaging Services Appoints John Rigg as Chief Executive Officer
Published: 2024-01-08 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.22%
H: 0.87%
C: -4.35%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
services
Totus Medicines Announces Appointment of Nassim Usman, Ph.D., as President & CEO and the Closing of a $66M Series B Funding
Published: 2023-12-15 (Crawled : 14:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
ceo series funding
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
Published: 2023-12-05 (Crawled : 15:30) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.34%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
GOSS 4 | $0.7061 -4.27% -4.46% 800K
|
Health Technology
|
| O: 1.27%
H: 5.99%
C: 4.97%
commercial
Cyclerion Appoints Regina Graul, Ph.D., as President
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.23%
H: 0.0%
C: 0.0%
CYCN | $3.05 -12.54% 720
|
Health Technology
|
| O: -4.29%
H: 5.67%
C: -4.62%
Almirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
Published: 2023-11-17 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.71%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
ebglyss dermatitis approval
QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.75%
H: 0.0%
C: 0.0%
QDEL | News 4 | $40.81 1.02% 1.0% 940K
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: -8.35%
results
Immuron achieves record quarterly Travelan® sales
Published: 2023-10-11 (Crawled : 10:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 6.48%
H: 4.35%
C: -5.22%
IMRN | $2.46 4.94% 1.3K
|
Health Technology
|
| O: 2.7%
H: 2.63%
C: -1.05%
travelan sales
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.